Abstract: Compounds, pharmaceutical compositions and methods for the therapeutic delivery of carbon monoxide to humans and other mammals that employ transition metal complexes having at least a substituted cyclopentadienyl, indenyl or fluorenyl ligand and two or more carbonyl ligands.

Abstract: Metal carbonyls are used to deliver CO having biological activity, for example vasodilatation and inhibition of transplant rejection. The metal of the carbonyl is typically of groups 7 to 10, e.g. Fe and Ru. The carbonyl preferably has one or store ligands other than CO, such as amine acids, to modulate the CO release property and solubility.

Abstract: Metal carbonyls are used to deliver CO to organs to limit post-ischaemic damage. The organ may be extracorporeal, e.g. for use in a transplant, or may be an isolated organ inside or attached to the body but isolated from the blood flow. The carbonyl preferably has one or more other ligands other than CO, such as amino acids, to modulate the CO release property and solubility.

Abstract: Compounds, pharmaceutical compositions and methods for the therapeutic delivery of carbon monoxide to humans and other mammals that employ transition metal complexes having at least a substituted cyclopentadienyl, indenyl or fluorenyl ligand and two or more carbonyl ligands.

Abstract: Compounds, pharmaceutical compositions and methods for the therapeutic delivery of carbon monoxide to humans and other mammals that employ Mn complexes having CO ligands, and additional halogen, monodentate and/or bidentate ligands, wherein the additional ligands do not occupy trans positions relative to each other.

Abstract: An improved in-building radio frequency communications system with automatic failover recovery comprising a primary external antenna and one ancillary external antenna, each antenna directed to a primary transmission tower and to an ancillary transmission tower, respectively, and a diversity site donor system capable of monitoring the strength and/or quality of the radio frequency signals received from the primary transmission tower and switching communications between the primary transmission tower and the ancillary transmission tower based on the strength and/or quality of the radio frequency signals received from the primary transmission tower.

Abstract: An improved in-building radio frequency communications system with automatic failover recovery comprising a primary external antenna and at least one ancillary external antenna, each antenna directed to a primary transmission tower and to at least one ancillary transmission tower, respectively, and a diversity site donor system capable of monitoring the strength and/or quality of the radio frequency signals received from the primary transmission tower and switching communications between the primary transmission tower and the ancillary transmission tower(s) based on the strength and/or quality of the radio frequency signals received from the primary transmission tower.

Abstract: An improved in-building radio frequency communications system with automatic failover recovery comprising a primary external antenna and at least one ancillary external antenna, each antenna directed to a primary transmission tower and to at least one ancillary transmission tower, respectively, and a diversity site donor system capable of monitoring the strength and/or quality of the radio frequency signals received from the primary transmission tower and switching communications between the primary transmission tower and the ancillary transmission tower(s) based on the strength and/or quality of the radio frequency signals received from the primary transmission tower.

Abstract: Metal carbonyls are used to deliver CO having biological activity, for example vasodilatation and inhibition of transplant rejection. The metal of the carbonyl is typically of groups 7 to 10, e.g. Fe and Ru. The carbonyl preferably has one or more ligands other than CO, such as amino acids, to modulate the CO release property and solubility.

Abstract: Metal carbonyls are used to deliver CO having biological activity, for example vasodilatation and inhibition of transplant rejection. The metal of the carbonyl is typically of groups 7 to 10, e.g. Fe and Ru. The carbonyl preferably has one or more ligands other than CO, such as amino acids, to modulate the CO release property and solubility.